Journal of the Korean Ophthalmological Society 2006;47(3):396-401.
Published online March 31, 2006.
Intravitreal Injection of Triamcinolone Acetonide on Refractory Uveitis.
Suk Kyue Choi, Young Jung Roh, Min Ho Kim
1Department of Ophthalmology, St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. youngjungroh@hanmail.net
2Apgujung St. Mary's Eye Center, Seoul, Korea.
불응성 포도막염에 대한 유리체내 트리암시놀론 주입효과
최석규1,노영정1,김민호2
Department of Ophthalmology, College of Medicine, The Catholic University1, Seoul, Korea Apgujung St. Mary`s Eye Center2, Seoul, Korea
Correspondence:  Suk Kyue Choi, M.D.
Abstract
PURPOSE
To investigate the effect of intravitreal injection of triamcinolone acetonide (4 mg) on refractory uveitis with cystoid macular edema (CME). METHODS: A retrospective observation survey was conducted on 21 eyes of 15 patients with refractory uveitis that had no response to immunosuppresants or systemic steroid therapy. Seven eyes were injected with triamcinolone acetonide intravitreally only, and fourteen eyes were injected during pars plana vitrectomy. At 3 and 12 months after triamcinolone acetonide injection, best corrected visual acuity and thickness of macula were measured by OCT. RESULTS: The average pre-treatment best corrected visual acuity was 0.18+/-0.08, and the average macular thickness was 534+/-132 micrometer. At 3 months after injection, the results for the same parameters were 0.45+/-0.18, 345+/-125 micrometer respectively. At 12 months after injection, they were 0.30+/-0.09, 498+/-133 micrometer respectively. Thus, best corrected visual acuity had improved and macular thickness had decreased at 3 months post-injection for the groups with intravitreal injection of triamcinolone acetonide and intravitreal injection during pars plana vitrectomy. However, these changes in best corrected visual acuity and macular thickness were not observed 12 months after injection. CONCLUSIONS: Intravitreal injection of triamcinolone acetonide had a temporary effect on refractory uveitis with cystoid macular edema (CME). However, a study that includes more participants will be necessary for conclusive evaluation.
Key Words: Cystoid macular edema;Refractory uveitis;Triamcinolone acetonide


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next